Experience

HanchorBio Inc.

• Taiwan
• Biotechnology Research
• 1 - 100 Employee

• Sr. Director of BD

  • May 2021 - Present

  • Develop company business development strategies, determine searching priorities to be aligned with the corporate strategy and identify target companies for both in-licensing and out-licensing opportunities • Perform financial modeling and commercial forecast in order to conduct financial analysis on target assets and on valuation of in-house assets • Facilitate scientific evaluations by leading and/or coordinating cross-functional and cross-disciplinary teams and execute initial pre-due diligence assessments and define the business criteria for potential in-licensing opportunities • Monitor the external industrial environment and maintain a knowledge base of licensing transactions and competitive intelligence • Strengthen company’s industry networking by presenting at the conferences or visiting potential partners to secure the identification of potential partnering opportunities Show less



XuanZhu Biopharmaceutical Ltd.

• China
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Sr. Director of Global Oncology BD

  • Sep 2019 - May 2021

  • Search and evaluate in-licensing opportunities both domestic and abroad, and identify pre-clinical, clinical and commercial stage assets especially in oncology disease area • Coordinate internal resources to conduct due diligence, data analysis and feasibility assessment to present to senior management for decision making • Responsible for in/out-licensing, co-development and collaboration programs via business meetings, contract negotiation, and project management • Search and evaluate in-licensing opportunities both domestic and abroad, and identify pre-clinical, clinical and commercial stage assets especially in oncology disease area • Coordinate internal resources to conduct due diligence, data analysis and feasibility assessment to present to senior management for decision making • Responsible for in/out-licensing, co-development and collaboration programs via business meetings, contract negotiation, and project management



Huahai US, Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Director/ Strategic Alliance Manager

  • Aug 2013 - Sep 2019

  • Work as Strategic Alliance Manager to maintain relationship with the Joint Venture partner and coordinate the efforts from both parties. • Review briefing books and filing documents submitted to regulatory agency from US, EU and China. • Participate the communication with the regulatory agencies from US, EU and China. • Lead the efforts for process and assay transfer to CMOs and CROs. • Participate the establishment of the biologics division for Huahai US Inc. • Work as Strategic Alliance Manager to maintain relationship with the Joint Venture partner and coordinate the efforts from both parties. • Review briefing books and filing documents submitted to regulatory agency from US, EU and China. • Participate the communication with the regulatory agencies from US, EU and China. • Lead the efforts for process and assay transfer to CMOs and CROs. • Participate the establishment of the biologics division for Huahai US Inc.



WuXi AppTec

• China
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Director

  • Jul 2012 - Aug 2013

  • Work as acting head of the department to oversee the daily operation of the overall analytical development and analytical support for biological process development and DS/DP production. • Lead the analytical development department to support product characterization and in-process analytical testing by use of various biochemical and biophysical methods including LC-MS and LC-MS/MS. • Lead impurities identification and characterization efforts for process development. • Lead a stability group to support all the DS and DP stability studies, forced degradation studies. • Lead QC lab in GMP manufacturing facility to oversee analytical method transfer, validation and daily operation. • Draft comparability and stability protocols for FDA submission. • Act as analytical lead in a joint venture program collaborating with a US biopharmaceutical company. Show less



Merck

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Sr. Research Biochemist

  • Sep 2010 - Jul 2012

  • Represent extended characterization group on cross-functional biological project teams for novel and biosimilar product development• Develop and implement extended characterization strategies to support Phase I IND filing• Review and write FDA regulatory submission and associated supporting technical reports and memos• Support extended characterization for therapeutic protein development using mass spectrometry and provide results for IND filing

• Sr. Research Chemist

  • Jul 2009 - Sep 2010

  • Develop methods to characterize therapeutic proteins and vaccines using mass spectrometry• Carry out characterization assay using mass spectrometry to support biologics and vaccine development• Evaluate and bring in new techniques for biologics analytical method development

• Sr. Research Chemist

  • Dec 2005 - Jul 2009

  • Develop methods to characterize biomarkers in plasma using LC/MS profiling• Develop methods to quantitate biomarkers in CSF and plasma using SRM QQQ assay• Investigate and implement protein identification solutions that support high-throughput proteomic studies• Maintain high-throughput LC/MS platforms including capillary HPLCs, autosamplers, and high end mass spectrometers such as QQQ, LCQ, LTQ, and LTQ-FTMS.